HEPATIC EXPRESSION OF A RECEPTOR-BINDING-DEFECTIVE HUMAN APOLIPOPROTEIN-E VARIANT CREATES A MODEL OF TYPE-III HYPERLIPOPROTEINEMIA IN TRANSGENIC MICE

被引：0
|
作者：
FAZIO, S [1 ]
SIMONET, WS [1 ]
RALL, SC [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94143
来源：
CIRCULATION | 1992年 / 86卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [31] APOLIPOPROTEIN-E2 ABNORMALITY IN TYPE-III HYPERLIPOPROTEINEMIA - MODULATION OF THE RECEPTOR-BINDING DOMAIN
    INNERARITY, TL
    WEISGRABER, KH
    RALL, SC
    MAHLEY, RW
    CLINICAL RESEARCH, 1983, 31 (02): : A460 - A460
  • [32] DEFECTIVE HEPATIC LIPOPROTEIN RECEPTOR-BINDING OF BETA VERY LOW-DENSITY LIPOPROTEINS FROM TYPE-III HYPERLIPOPROTEINEMIC PATIENTS IMPORTANCE OF APOLIPOPROTEIN-E
    HUI, DY
    INNERARITY, TL
    MAHLEY, RW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (02) : 860 - 869
  • [33] SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEIN-E PHENOTYPES IN RELATIVES OF PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA
    STUYT, PMJ
    DEMACKER, PNM
    VANTLAAR, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (03) : 219 - 226
  • [34] REGULATION AND EXPRESSION OF THE HUMAN APOLIPOPROTEIN-E GENE IN TRANSGENIC MICE
    TAYLOR, JM
    SIMONET, WS
    LAUER, SJ
    ZHU, GM
    WALKER, D
    CURRENT OPINION IN LIPIDOLOGY, 1993, 4 (02) : 84 - 89
  • [35] STRUCTURAL BASIS FOR RECEPTOR-BINDING HETEROGENEITY OF APOLIPOPROTEIN-E FROM TYPE-III HYPERLIPOPROTEINEMIC SUBJECTS
    RALL, SC
    WEISGRABER, KH
    INNERARITY, TL
    MAHLEY, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (15): : 4696 - 4700
  • [36] APOLIPOPROTEIN-E ISOFORMS AND RARE MUTATIONS - PARALLEL REDUCTION IN BINDING TO CELLS AND TO HEPARIN REFLECTS SEVERITY OF ASSOCIATED TYPE-III HYPERLIPOPROTEINEMIA
    MANN, WA
    MEYER, N
    WEBER, W
    MEYER, S
    GRETEN, H
    BEISIEGEL, U
    JOURNAL OF LIPID RESEARCH, 1995, 36 (03) : 517 - 525
  • [37] Type III hyperlipoproteinemic transgenic rabbits with defective human apolipoprotein E
    Huang, YD
    Schwendner, SW
    Rall, SC
    Taylor, S
    Mahley, RW
    CIRCULATION, 1996, 94 (08) : 3031 - 3031
  • [38] IDENTIFICATION OF A NEW APOLIPOPROTEIN-E VARIANT (E(2) ARG(142)-]LEU) IN TYPE-III HYPERLIPIDEMIA
    RICHARD, P
    DEZULUETA, MP
    BEUCLER, I
    DEGENNES, JL
    CASSAIGNE, A
    IRON, A
    ATHEROSCLEROSIS, 1995, 112 (01) : 19 - 28
  • [39] INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA-LIPID AND APOLIPOPROTEIN LEVELS, AND CLINICAL CHARACTERISTICS OF TYPE-III HYPERLIPOPROTEINEMIA DUE TO APOLIPOPROTEIN-E PHENOTYPE-E2/2 IN JAPAN
    KOBORI, S
    NAKAMURA, N
    UZAWA, H
    SHICHIRI, M
    ATHEROSCLEROSIS, 1988, 69 (01) : 81 - 88
  • [40] APOLIPOPROTEIN E3-LEIDEN - A NEW VARIANT OF HUMAN APOLIPOPROTEIN-E ASSOCIATED WITH FAMILIAL TYPE-3 HYPERLIPOPROTEINEMIA
    HAVEKES, L
    DEWIT, E
    LEUVEN, JG
    KLASEN, E
    UTERMANN, G
    WEBER, W
    BEISIEGEL, U
    HUMAN GENETICS, 1986, 73 (02) : 157 - 163
12345